1. Home
  2. NUVL vs SSD Comparison

NUVL vs SSD Comparison

Compare NUVL & SSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$123.60

Market Cap

9.8B

Sector

Health Care

ML Signal

HOLD

Logo Simpson Manufacturing Company Inc.

SSD

Simpson Manufacturing Company Inc.

HOLD

Current Price

$205.38

Market Cap

8.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
SSD
Founded
2017
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.8B
8.2B
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
NUVL
SSD
Price
$123.60
$205.38
Analyst Decision
Strong Buy
Buy
Analyst Count
16
4
Target Price
$134.75
$214.75
AVG Volume (30 Days)
4.1M
327.1K
Earning Date
05-08-2026
04-27-2026
Dividend Yield
N/A
0.61%
EPS Growth
N/A
8.42
EPS
N/A
2.13
Revenue
N/A
$2,332,808,000.00
Revenue This Year
N/A
$3.82
Revenue Next Year
$1,239.49
$5.57
P/E Ratio
N/A
$95.51
Revenue Growth
N/A
4.51
52 Week Low
$71.14
$156.32
52 Week High
$123.69
$213.49

Technical Indicators

Market Signals
Indicator
NUVL
SSD
Relative Strength Index (RSI) 66.56 60.43
Support Level $98.56 $163.08
Resistance Level $123.62 $211.98
Average True Range (ATR) 0.21 5.57
MACD -0.05 1.03
Stochastic Oscillator 82.41 67.44

Price Performance

Historical Comparison
NUVL
SSD

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About SSD Simpson Manufacturing Company Inc.

Simpson Manufacturing Co Inc designs, manufactures, and markets systems and products to make buildings and structures safe and secure. It produces wood construction products, including connectors, truss plates, fastening systems, fasteners, and shearwalls, as well as concrete construction products such as adhesives, specialty chemicals, mechanical anchors, powder actuated tools, and fiber reinforcing materials. The company serves residential, industrial, commercial, and infrastructure construction, remodeling, and do-it-yourself markets, operating exclusively in the building products industry. It has three regional segments: North America, Europe, and Asia/Pacific. The majority of its revenue comes from wood products.

Share on Social Networks: